Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening

Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announced a collaboration aimed at enhancing colorectal cancer (CRC) screening methods.

ZYMO RESEARCH LAUNCHES THE OMICS DISCOVERY GRANT TO ADVANCE RNA-SEQ RESEARCH

https://www.zymoresearch.com/blogs/press-releases/omics-discovery-grant-launch Apply for Zymo Research's Omics Discovery Grant for cutting-edge RNA-Seq tools worth $4000.

SMi Systems appoints Dr Stefan Hamill as VP of Strategy

SMi Systems announces the appointment of Dr Stefan Hamill as its Vice President of Strategy. Dr Hamill was formerly a senior analyst at investment banks Numis (now Deutsche Numis) and Peel Hunt, both of which he helped transform into #1 ranked franchises in UK Life Sciences.

Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2024

DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification

DoseMe, a leading provider of model-informed precision dosing (MIPD), announced today it has earned certified status by HITRUST for information security. HITRUST Risk-based, 2-year (r2) Certification demonstrates that the organization’s DoseMeRX has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places DoseMe in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls. DoseMe remains the only model informed precision dosing platform to achieve the r2 Certification.

Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership

The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women

Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access

Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access. One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.

ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market

CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia

CG Life Forms Strategic Communications Group to Integrate Corporate, Scientific and Medical Communications and Social Media Services

Optibrium Demonstrates Accelerated Lead Optimisation in Complex Agrochemical Development

Optibrium announced the publication of a peer-reviewed study in Journal of Computer-Aided Molecular Design, ‘From UK-2A to florylpicoxamid: Active learning to identify a mimic of a macrocyclic natural product’. The paper demonstrates the successful application of the QuanSA (Quantitative Surface-field Analysis) method, part of Optibrium’s BioPharmics platform for 3D molecular design, to accelerate the lead optimisation of a complex macrocyclic natural product during agrochemical development. By significantly reducing the number of synthetic steps required during optimisation, the study supports the commercial viability of complex macrocyclic compounds.

Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform

Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.

CellMaker bioreactor systems rely on Watson-Marlow’s 300 series laboratory pumps for ease of use and flexibility

Watson-Marlow’s 323Du/D and 323Du/RL peristaltic pumps are available as an accessory with the CellMaker single-use bioreactor systems

AKASA Earns 2024 Great Place To Work Certification™

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ability to deliver therapeutics directly to the colon

Genuus Asia Launches Cutting-Edge B2B Digital Marketing Solutions

Genuus Asia, a prominent name in digital marketing innovation, proudly announces the launch of its comprehensive B2B digital marketing services.

DoseMe Enhances Web-based User Experience and Capability to Further Scale its Precision Dosing Platform

DoseMe, a leading provider of model-informed precision dosing (MIPD) software, announced today the general availability of its enhanced web-based platform. These technical improvements streamline the workflow and offer the same user experience as fully integrated DoseMeRx customers. This change offers caregivers improved efficiencies.

Cytiva’s latest innovation significantly improves filtration of high concentration biologics

WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

WCG and the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard are leading a multi-stakeholder task force to address ethical and regulatory challenges in the IRB review of clinical research protocols that use AI.

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).